| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.25 | 1e-05 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.5 | 2e-05 |